Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Price:
450.41
USD
-0.58%
Market Closed
Market Cap:
$114.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
N
|
Nestle SA
XBER:NESR
|
CH |
|
EcoSynthetix Inc
F:0Y8
|
CA |
|
Relevium Technologies Inc
XTSX:RLV
|
CA |
|
W
|
Willis Towers Watson PLC
SWB:WTY
|
UK |
|
S
|
SVI PCL
SET:SVI
|
TH |
|
China Citic Bank Corp Ltd
OTC:CHBJF
|
CN |
|
Moody's Corp
BMV:MCO
|
US |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
Kronos Worldwide Inc
NYSE:KRO
|
US |
|
Alector Inc
NASDAQ:ALEC
|
US |
|
Adani Green Energy Ltd
NSE:ADANIGREEN
|
IN |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Caixabank SA
MAD:CABK
|
ES |
|
Interglobe Aviation Ltd
NSE:INDIGO
|
IN |
|
D
|
Distell Group Holdings Ltd
JSE:DGH
|
ZA |
|
T
|
Thoresen Thai Agencies PCL
SET:TTA
|
TH |
|
Casella Waste Systems Inc
NASDAQ:CWST
|
US |
Multiples-Based Value
The Multiples-Based Value for Vertex Pharmaceuticals Inc (VRTX) under the Base Case is hidden
USD.
Compared with the current market price of 450.41 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VRTX Multiples-Based Value
LOCKED
